An internal standard for the quantification of hemokinin 1
Related Products
Unlabeled Version(s)
35458Hemokinin 1 (human) (trifluoroacetate salt)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Hemokinin 1-d10 (human) (trifluoroacetate salt)

Item No. 44813

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
(2S)-2-((2S,5S,8S,14S,15R)-14-amino-8-(4-aminobutyl)-15-hydroxy-2-(hydroxymethyl)-5-methyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazahexadecanamido)-N1-((5S,14S,17S)-14-benzyl-5-carbamoyl-8-(2-(methyl-d3)propyl-1,1,2,3,3,3-d6)-7,10,13,16-tetraoxo-18-phenyl-2-thia-6,9,12,15-tetraazaoctadecan-17-yl-8-d)pentanediamide, trifluoroacetate salt
Synonyms
  • HK-1-d10
  • Tachykinin-4 (57-67)-d10
Molecular Formula
C54H74D10N14O14S • XCF3COOH
Formula Weight
1195.5
Purity
≥95%
Formulation (Request formulation change)
A solid
Peptide Sequence
TGKASQFFG[L-d10]M-NH2
Solubility(Learn about Variance in Solubility)
Water: Soluble
SMILES
CSCC[C@@H](C(N)=O)NC(C(C([2H])([2H])C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])([2H])NC(CNC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@H](CCC(N)=O)NC([C@H](CO)NC([C@H](C)NC([C@H](CCCCN)NC(CNC([C@@H](N)[C@H](O)C)=O)=O)=O)=O)=O)=O)CC2=CC=CC=C2)=O)=O)=O)=O.O=C(O)C(F)(F)F
InChi Code
InChI=1S/C54H84N14O14S.C2HF3O2/c1-30(2)24-38(51(79)64-35(46(58)74)21-23-83-5)63-44(73)27-59-48(76)39(25-33-14-8-6-9-15-33)66-52(80)40(26-34-16-10-7-11-17-34)67-50(78)37(19-20-42(56)71)65-53(81)41(29-69)68-47(75)31(3)61-49(77)36(18-12-13-22-55)62-43(72)28-60-54(82)45(57)32(4)70;3-2(4,5)1(6)7/h6-11,14-17,30-32,35-41,45,69-70H,12-13,18-29,55,57H2,1-5H3,(H2,56,71)(H2,58,74)(H,59,76)(H,60,82)(H,61,77)(H,62,72)(H,63,73)(H,64,79)(H,65,81)(H,66,80)(H,67,78)(H,68,75);(H,6,7)/t31-,32+,35-,36-,37-,38?,39-,40-,41-,45-;/m0./s1/i1D3,2D3,24D2,30D,38D;
InChi Key
QLLAEPTWWMMZIN-UBLMBUGESA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    500 µg

    $275

    Add

    1 mg

    $495

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Hemokinin 1-d10 is intended for use as an internal standard for the quantification of hemokinin 1 (Item No. 35458) by GC- or LC-MS. Hemokinin 1 is a tachykinin peptide neurokinin-1 (NK1) receptor agonist.1,2,3,4,5 It induces migration of A375 and B16/F10 melanoma cells when used at a concentration of 1 µM, an effect that can be reversed by the NK1 receptor antagonist L-732,138 (Item No. 30894).1 Hemokinin 1 (0.001-0.1 µM) promotes the proliferation, migration, and tube formation of human umbilical vein endothelial cells (HUVECs).2 It induces the production of prostaglandin E2 (PGE2; Item No. 14010) in human colon mucosal and muscle explants.3 Intracerebroventricular administration of hemokinin 1 increases the latency to withdrawal in the tail-flick test in mice in a dose-dependent manner.4 It decreases mean arterial pressure (MAP) and heart rate in anesthetized rats when administered at doses ranging from 1 to 30 nmol/kg.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zhang, Y., Li, X., Li, J., et al. Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors. Peptides 83, 8-15 (2016).

    2. Song, H., Yin, W., Zeng, Q., et al. Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor. Int. J. Biochem. Cell Biol. 44(9), 1410-1421 (2012).

    3. Dai, L., Perera, D.S., King, D.W., et al. Hemokinin-1 stimulates prostaglandin E2 production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase. J. Pharmacol. Exp. Ther. 340(1), 27-36 (2012).

    4. Fu, C.Y., Zhao, Y.L., Dong, L., et al. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice. Brain Behav. Immun. 22(6), 850-860 (2008).

    5. Kong, Z.-Q., Fu, C.-Y., Chen, Q., et al. Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats. Eur. J. Pharmacol. 590(1-3), 310-316 (2008).